Keywords
Last Name
Institution

Robert C Wilson

Title
InstitutionMedical University of South Carolina
DepartmentPathology and Laboratory Medicine
AddressP.O. Box MSC 908
BEB 414
68 President St.
Phone843-876-2217
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Solanki AK, Arif E, Morinelli T, Wilson RC, Hardiman G, Deng P, Arthur JM, Velez JC, Nihalani D, Janech MG, Budisavljevic MN. A Novel CLCN5 Mutation Associated With Focal Segmental Glomerulosclerosis and Podocyte Injury. Kidney Int Rep. 2018 Nov; 3(6):1443-1453. PMID: 30426109.
      View in: PubMed
    2. Yau M, Haider S, Khattab A, Ling C, Mathew M, Zaidi S, Bloch M, Patel M, Ewert S, Abdullah W, Toygar A, Mudryi V, Al Badi M, Alzubdi M, Wilson RC, Al Azkawi HS, Ozdemir HN, Abu-Amer W, Hertecant J, Razzaghy-Azar M, Funder JW, Al Senani A, Sun L, Kim SM, Yuen T, Zaidi M, New MI. Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11ß-hydroxysteroid dehydrogenase type 2 deficiency. Proc Natl Acad Sci U S A. 2017 12 26; 114(52):E11248-E11256. PMID: 29229831.
      View in: PubMed
    3. Labuzzetta CJ, Antonio ML, Watson PM, Wilson RC, Laboissonniere LA, Trimarchi JM, Genc B, Ozdinler PH, Watson DK, Anderson PE. Complementary feature selection from alternative splicing events and gene expression for phenotype prediction. Bioinformatics. 2016 09 01; 32(17):i421-i429. PMID: 27587658.
      View in: PubMed
    4. Yau M, Azkawi HS, Haider S, Khattab A, Badi MA, Abdullah W, Senani AA, Wilson RC, Yuen T, Zaidi M, New MI. A novel mutation in HSD11B2 causes apparent mineralocorticoid excess in an Omani kindred. Ann N Y Acad Sci. 2016 07; 1376(1):65-71. PMID: 27526338.
      View in: PubMed
    5. Hardiman G, Savage SJ, Hazard ES, Wilson RC, Courtney SM, Smith MT, Hollis BW, Halbert CH, Gattoni-Celli S. Systems analysis of the prostate transcriptome in African-American men compared with European-American men. Pharmacogenomics. 2016 07; 17(10):1129-1143. PMID: 27359067.
      View in: PubMed
    6. Guest ST, Kratche ZR, Irish JC, Wilson RC, Haddad R, Gray JW, Garrett-Mayer E, Ethier SP. Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death. Oncotarget. 2016 Jun 14; 7(24):36138-36153. PMID: 27153554.
      View in: PubMed
    7. Paul MR, Levitt NP, Moore DE, Watson PM, Wilson RC, Denlinger CE, Watson DK, Anderson PE. Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA. BMC Genomics. 2016 Mar 31; 17:263. PMID: 27029813.
      View in: PubMed
    8. Dumic KK, Grubic Z, Yuen T, Wilson RC, Kusec V, Barisic I, Stingl K, Sansovic I, Skrabic V, Dumic M, New MI. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia. J Steroid Biochem Mol Biol. 2017 01; 165(Pt A):51-56. PMID: 27041116.
      View in: PubMed
    9. Irish JC, Mills JN, Turner-Ivey B, Wilson RC, Guest ST, Rutkovsky A, Dombkowski A, Kappler CS, Hardiman G, Ethier SP. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERa in SUM-44 breast cancer cells and is associated with ERa over-expression in breast cancer. Mol Oncol. 2016 06; 10(6):850-65. PMID: 27005559.
      View in: PubMed
    10. Scheiber MN, Watson PM, Rumboldt T, Stanley C, Wilson RC, Findlay VJ, Anderson PE, Watson DK. FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia. 2014 Oct; 16(10):801-13. PMID: 25379017.
      View in: PubMed
    11. Kappler CS, Guest ST, Irish JC, Garrett-Mayer E, Kratche Z, Wilson RC, Ethier SP. Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Mol Oncol. 2015 Feb; 9(2):527-43. PMID: 25454348.
      View in: PubMed
    12. Turner-Ivey B, Guest ST, Irish JC, Kappler CS, Garrett-Mayer E, Wilson RC, Ethier SP. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55. PMID: 25220592.
      View in: PubMed
    13. New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, Sun L, Zaidi M, Wilson RC, Yuen T. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2013 Feb 12; 110(7):2611-6. PMID: 23359698.
      View in: PubMed
    14. George MM, Sinha S, Mamkin I, Philibert P, New MI, Wilson RC, Sultan C, Ten S, Bhangoo A. Isolated mild clitoral hypertrophy may reveal 46,XY disorders of sex development in infancy due to 17ßHSD-3 defect confirmed by molecular analysis. Gynecol Endocrinol. 2011 Nov; 27(11):890-4. PMID: 21214500.
      View in: PubMed
    15. Bas F, Kayserili H, Darendeliler F, Uyguner O, Günöz H, Yüksel Apak M, Atalar F, Bundak R, Wilson RC, New MI, Wollnik B, Saka N. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children. J Clin Res Pediatr Endocrinol. 2009; 1(3):116-28. PMID: 21274396.
      View in: PubMed
    16. Wilson RC, Nimkarn S, Dumic M, Obeid J, Azar MR, Azar M, Najmabadi H, Saffari F, New MI. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab. 2007 Apr; 90(4):414-21. PMID: 17275379.
      View in: PubMed
    17. Nimkarn S, Lin-Su K, Berglind N, Wilson RC, New MI. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2007 Jan; 92(1):137-42. PMID: 17032723.
      View in: PubMed
    18. Ergun-Longmire B, Auchus R, Papari-Zareei M, Tansil S, Wilson RC, New MI. Two novel mutations found in a patient with 17alpha-hydroxylase enzyme deficiency. J Clin Endocrinol Metab. 2006 Oct; 91(10):4179-82. PMID: 16849412.
      View in: PubMed
    19. Keen-Kim D, Redman JB, Alanes RU, Eachus MM, Wilson RC, New MI, Nakamoto JM, Fenwick RG. Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency). J Mol Diagn. 2005 May; 7(2):236-46. PMID: 15858147.
      View in: PubMed
    20. New MI, Geller DS, Fallo F, Wilson RC. Monogenic low renin hypertension. Trends Endocrinol Metab. 2005 Apr; 16(3):92-7. PMID: 15808805.
      View in: PubMed
    21. Motaghedi R, Betensky BP, Slowinska B, Cerame B, Cabrer M, New MI, Wilson RC. Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2005 Feb; 18(2):133-42. PMID: 15751602.
      View in: PubMed
    22. Chemaitilly W, Betensky BP, Marshall I, Wei JQ, Wilson RC, New MI. The natural history and genotype-phenotype nonconcordance of HLA identical siblings with the same mutations of the 21-hydroxylase gene. J Pediatr Endocrinol Metab. 2005 Feb; 18(2):143-53. PMID: 15751603.
      View in: PubMed
    23. Lin-Su K, Zhou P, Arora N, Betensky BP, New MI, Wilson RC. In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 2004 May; 89(5):2024-7. PMID: 15126515.
      View in: PubMed
    24. Dumic M, Ille J, Zunec R, Plavsic V, Francetic I, Skrabic V, Janjanin N, Spehar A, Wei J, Wilson RC, New MI. Nonclassic 21-hydroxylase deficiency in Croatia. J Pediatr Endocrinol Metab. 2004 Feb; 17(2):157-64. PMID: 15055349.
      View in: PubMed
    25. Chemaitilly W, Wilson RC, New MI. Hypertension and adrenal disorders. Curr Hypertens Rep. 2003 Dec; 5(6):498-504. PMID: 14594571.
      View in: PubMed
    26. New MI, Carlson A, Obeid J, Marshall I, Cabrera MS, Goseco A, Lin-Su K, Putnam AS, Wei JQ, Wilson RC. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab. 2001 Dec; 86(12):5651-7. PMID: 11739415.
      View in: PubMed
    27. Wilson RC, Nimkarn S, New MI. Apparent mineralocorticoid excess. Trends Endocrinol Metab. 2001 Apr; 12(3):104-11. PMID: 11306334.
      View in: PubMed
    28. New MI, Nimkarn S, Brandon DD, Cunningham-Rundles S, Wilson RC, Newfield RS, Vandermeulen J, Barron N, Russo C, Loriaux DL, O'Malley B. Resistance to multiple steroids in two sisters. J Steroid Biochem Mol Biol. 2001 Jan-Mar; 76(1-5):161-6. PMID: 11384874.
      View in: PubMed
    29. Ugrasbul F, Wiens T, Rubinstein P, New MI, Wilson RC. Prevalence of mild apparent mineralocorticoid excess in Mennonites. J Clin Endocrinol Metab. 1999 Dec; 84(12):4735-8. PMID: 10599743.
      View in: PubMed
    30. New MI, Obeid J, Wilson RC, Cabrera MS, Goseco A, Macapagal MC, Marshall I, Nimkarn S, Quintos JB, Ten S, Ugrasbul F, Vandermolen L, Harbison MD. Profile of the pediatric endocrine clinic at New York-Presbyterian Hospital, New York Weill Cornell Center. J Clin Endocrinol Metab. 1999 Dec; 84(12):4444-9. PMID: 10599700.
      View in: PubMed
    31. New MI, Nimkarn S, Brandon DD, Cunningham-Rundles S, Wilson RC, Newfield RS, Vandermeulen J, Barron N, Russo C, Loriaux DL, O'Malley B. Resistance to several steroids in two sisters. J Clin Endocrinol Metab. 1999 Dec; 84(12):4454-64. PMID: 10599702.
      View in: PubMed
    32. Spiro RP, Christian SL, Ledbetter DH, New MI, Wilson RC, Roizen N, Rosenfield RL. Intrauterine growth retardation associated with maternal uniparental disomy for chromosome 6 unmasked by congenital adrenal hyperplasia. Pediatr Res. 1999 Nov; 46(5):510-3. PMID: 10541311.
      View in: PubMed
    33. New MI, Wilson RC. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci U S A. 1999 Oct 26; 96(22):12790-7. PMID: 10536001.
      View in: PubMed
    34. Cerame BI, Newfield RS, Pascoe L, Curnow KM, Nimkarn S, Roe TF, New MI, Wilson RC. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia. J Clin Endocrinol Metab. 1999 Sep; 84(9):3129-34. PMID: 10487675.
      View in: PubMed
    35. Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol. 1999 Apr-Jun; 69(1-6):19-29. PMID: 10418977.
      View in: PubMed
    36. Nimkarn S, Cerame BI, Wei JQ, Dumic M, Zunec R, Brkljacic L, Skrabic V, New MI, Wilson RC. Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations. J Clin Endocrinol Metab. 1999 Jan; 84(1):378-81. PMID: 9920112.
      View in: PubMed
    37. Wilson RC, Dave-Sharma S, Wei JQ, Obeyesekere VR, Li K, Ferrari P, Krozowski ZS, Shackleton CH, Bradlow L, Wiens T, New MI. A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci U S A. 1998 Aug 18; 95(17):10200-5. PMID: 9707624.
      View in: PubMed
    Wilson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _